サマリー

ダリア病治療薬の世界市場 2022-2026 年
TechnavioはDarier病治療薬市場を監視しており、2022-2026年の間に4537万ドルの成長が見込まれ、予測期間中にCAGR4.6％で加速しています。当レポートでは、ダリア病治療薬市場の全体分析、市場規模・予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、高度な皮膚科学的診断に対する需要の増加、新しいダリア病治療薬の発売、最小限のモニタリングで済む安全で安定した医薬品へのニーズによって牽引されています。
ダリアー病治療薬市場の分析には、製品セグメントや地理的な状況も含まれます。
Technavioのダリアー病治療薬市場は以下のようにセグメント化されています。
製品別
- 局所用レチノイド
- 経口レチノイド
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、遺伝子治療に関する研究の増加が、今後数年間におけるダリア病治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、皮膚科治療薬の価格上昇と治療におけるレーザーの普及が、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。ダリア病治療薬市場に関する当レポートの対象領域は以下の通りです。
- ダリア病治療薬市場のサイジング
- ダリア病治療薬市場の予測
- ダリア病治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Amneal Pharmaceuticals Inc、Bausch Health Companies Inc、BridgeBio Pharma Inc、Galderma SA、GlaxoSmithKline Plc、Glenmark Pharmaceuticals Ltd.、Johnson and Johnson、Laminar Pharma、Mayne Pharma Group Ltd、Merck and Co., Ltd.を含むいくつかの主要Darier disease drugs市場ベンダーについての詳細分析を提供しています。Ltd.、ノバルティスAG、ファイザー株式会社、沢井製薬株式会社、日本ケミコン株式会社、日本ケミコン株式会社、日本ケミコン株式会社Ltd.、Sigmapharm Laboratories LLC、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Tolmar Pharmaceuticals Inc.、Validus Pharmaceuticals LLC、Viatris Inc.の7社であります。また、ダリア病治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/darier-disease-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Topical retinoids - Market size and forecast 2021-2026
o Exhibit 28: Chart on Topical retinoids - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Topical retinoids - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Topical retinoids - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Topical retinoids - Year-over-year growth 2021-2026 (%)
o 5.4 Oral retinoids - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oral retinoids - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Oral retinoids - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Oral retinoids - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oral retinoids - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bausch Health Companies Inc.
o Exhibit 89: Bausch Health Companies Inc. - Overview
o Exhibit 90: Bausch Health Companies Inc. - Business segments
o Exhibit 91: Bausch Health Companies Inc. - Key news
o Exhibit 92: Bausch Health Companies Inc. - Key offerings
o Exhibit 93: Bausch Health Companies Inc. - Segment focus
o 10.4 BridgeBio Pharma Inc.
o Exhibit 94: BridgeBio Pharma Inc. - Overview
o Exhibit 95: BridgeBio Pharma Inc. - Product / Service
o Exhibit 96: BridgeBio Pharma Inc. - Key offerings
o 10.5 Galderma SA
o Exhibit 97: Galderma SA - Overview
o Exhibit 98: Galderma SA - Product / Service
o Exhibit 99: Galderma SA - Key news
o Exhibit 100: Galderma SA - Key offerings
o 10.6 GlaxoSmithKline Plc
o Exhibit 101: GlaxoSmithKline Plc - Overview
o Exhibit 102: GlaxoSmithKline Plc - Business segments
o Exhibit 103: GlaxoSmithKline Plc - Key news
o Exhibit 104: GlaxoSmithKline Plc - Key offerings
o Exhibit 105: GlaxoSmithKline Plc - Segment focus
o 10.7 Glenmark Pharmaceuticals Ltd.
o Exhibit 106: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 107: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 108: Glenmark Pharmaceuticals Ltd. - Key offerings
o 10.8 Mayne Pharma Group Ltd.
o Exhibit 109: Mayne Pharma Group Ltd. - Overview
o Exhibit 110: Mayne Pharma Group Ltd. - Business segments
o Exhibit 111: Mayne Pharma Group Ltd. - Key news
o Exhibit 112: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 113: Mayne Pharma Group Ltd. - Segment focus
o 10.9 Novartis AG
o Exhibit 114: Novartis AG - Overview
o Exhibit 115: Novartis AG - Business segments
o Exhibit 116: Novartis AG - Key offerings
o Exhibit 117: Novartis AG - Segment focus
o 10.10 Sigmapharm Laboratories LLC
o Exhibit 118: Sigmapharm Laboratories LLC - Overview
o Exhibit 119: Sigmapharm Laboratories LLC - Product / Service
o Exhibit 120: Sigmapharm Laboratories LLC - Key offerings
o 10.11 Sun Pharmaceutical Industries Ltd.
o Exhibit 121: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 123: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.12 Tolmar Pharmaceuticals Inc.
o Exhibit 124: Tolmar Pharmaceuticals Inc. - Overview
o Exhibit 125: Tolmar Pharmaceuticals Inc. - Product / Service
o Exhibit 126: Tolmar Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Topical retinoids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Topical retinoids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Topical retinoids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Topical retinoids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oral retinoids - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Oral retinoids - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Oral retinoids - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oral retinoids - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bausch Health Companies Inc. - Overview
Exhibits90: Bausch Health Companies Inc. - Business segments
Exhibits91: Bausch Health Companies Inc. - Key news
Exhibits92: Bausch Health Companies Inc. - Key offerings
Exhibits93: Bausch Health Companies Inc. - Segment focus
Exhibits94: BridgeBio Pharma Inc. - Overview
Exhibits95: BridgeBio Pharma Inc. - Product / Service
Exhibits96: BridgeBio Pharma Inc. - Key offerings
Exhibits97: Galderma SA - Overview
Exhibits98: Galderma SA - Product / Service
Exhibits99: Galderma SA - Key news
Exhibits100: Galderma SA - Key offerings
Exhibits101: GlaxoSmithKline Plc - Overview
Exhibits102: GlaxoSmithKline Plc - Business segments
Exhibits103: GlaxoSmithKline Plc - Key news
Exhibits104: GlaxoSmithKline Plc - Key offerings
Exhibits105: GlaxoSmithKline Plc - Segment focus
Exhibits106: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits107: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits108: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits109: Mayne Pharma Group Ltd. - Overview
Exhibits110: Mayne Pharma Group Ltd. - Business segments
Exhibits111: Mayne Pharma Group Ltd. - Key news
Exhibits112: Mayne Pharma Group Ltd. - Key offerings
Exhibits113: Mayne Pharma Group Ltd. - Segment focus
Exhibits114: Novartis AG - Overview
Exhibits115: Novartis AG - Business segments
Exhibits116: Novartis AG - Key offerings
Exhibits117: Novartis AG - Segment focus
Exhibits118: Sigmapharm Laboratories LLC - Overview
Exhibits119: Sigmapharm Laboratories LLC - Product / Service
Exhibits120: Sigmapharm Laboratories LLC - Key offerings
Exhibits121: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits122: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits123: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits124: Tolmar Pharmaceuticals Inc. - Overview
Exhibits125: Tolmar Pharmaceuticals Inc. - Product / Service
Exhibits126: Tolmar Pharmaceuticals Inc. - Key offerings
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations